ABBV-RGX-314 continues to be well tolerated in 50 patients from dose levels 1 and 2 (Cohorts 1-3) with no drug-related serious adverse events Dose level 2 prevented disease progression and reduced...

- SION-719 and SION-451, combined with complementary CFTR modulators, fully restore ΔF508-CFTR maturation, trafficking, and function to wild-type levels in CFHBE model and other preclinical systems -

Integral Molecular, a leading biotech company specializing in antibody discovery against undruggable protein targets will present multispecific molecules targeting GPRC5D, BCMA, and CD3 this week...

Major Conference Discussing the Evolving and Expanding Need for Oncology Patient Navigators CRANBURY, N.J., Nov. 3, 2023 /PRNewswire/ -- Finally recognized as a vital part of a cancer patient's...

"Hosted by Hypertension Expert and Lifestyle Medicine Trailblazer, Laurie Marbas, MD, MBA" Key Takeaways: Learn powerful lifestyle and nutritional strategies to combat hypertension. Connect with...